Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

Authors

Niklas Mattsson-Carlgren, Lund University
Shorena Janelidze, Lund University
Randall J Bateman, Washington University School of Medicine in St. Louis
Ruben Smith, Lund University
Erik Stomrud, Lund University
Geidy E Serrano, Banner Alzheimer's Institute
Eric M Reiman, Banner Alzheimer's Institute
Sebastian Palmqvist, Lund University
Jeffrey L Dage, Eli Lilly and Company
Thomas G Beach, Banner Sun Health Research Institute
Oskar Hansson, Washington University School of Medicine in St. Louis

Journal

EMBO Molecular Medicine

Publication Date

6-7-2021

Volume

13

Issue

6

First Page

e14022

Document Type

Open Access Publication

DOI

10.15252/emmm.202114022

Rights and Permissions

Mattsson-Carlgren N, Janelidze S, Bateman RJ, Smith R, Stomrud E, Serrano GE, Reiman EM, Palmqvist S, Dage JL, Beach TG, Hansson O. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. EMBO Mol Med. 2021 Jun 7;13(6):e14022. doi: 10.15252/emmm.202114022. © 2021 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Mattsson-Carlgren, Niklas; Janelidze, Shorena; Bateman, Randall J; Smith, Ruben; Stomrud, Erik; Serrano, Geidy E; Reiman, Eric M; Palmqvist, Sebastian; Dage, Jeffrey L; Beach, Thomas G; and Hansson, Oskar, "Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau." EMBO Molecular Medicine. 13, 6. e14022 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10738